Trusted Resources

Tafamidis Survival
Jun 24, 2024
Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)
ABSTRACTBackgroundIn the pivotal Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT), tafamidis significantly reduced mortality rates, leading to…
Read more
ScienceDirect
Jun 19, 2024
Right ventricular myocardial biopsy with a guiding catheter for conduction system pacing during pacemaker implantation revealed transthyretin cardiac amyloidosis
IntroductionTransthyretinexternal link, opens in a new tab amyloid cardiomyopathyexternal link, opens in a new tab (ATTR-CM) is a progressive disease that causes…
Read more
Springer Link
Jun 04, 2024
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings
IntroductionHereditary transthyretin amyloidosis (ATTRv, also referred to as hATTR; ORPHA 271861) and wild-type ATTR amyloidosis (ATTRwt; ORPHA 330001) are rare,…
Read more
MDPI
May 28, 2024
Advancing Renal Amyloidosis Care: The Role f Modern Diagnostic Techniques with the Potential of Enhancing Patient Outcomes
Renal amyloidosis is a set of complex disorders characterized by the deposition of amyloid proteins in the kidneys, which causes gradual organ damage and potential…
Read more
Springer Link
May 06, 2024
Changes in the diagnostic trajectory of transthyretin cardiac amyloidosis over six years
Awareness of transthyretin amyloid cardiomyopathy (ATTR-CM) has increased over the years due to diagnostic and therapeutic developments. Timely initiation of novel…
Read more
nukleertipseminerleri
May 04, 2024
Procedure Guideline for Scintigraphic Imaging in Cardiac Transthyretin Amyloidosis
Amyloidosis is a systemic disorder characterized by the extracellular deposition of amyloid fibrils in various tissues, with the potential for cardiac involvement.…
Read more
Subscribe to